Elizabeth Olson Hexner, MD, MSTR
Associate Professor of Medicine (Hematology-Oncology) at the Hospital of the University of Pennsylvania
Co-Director, MSTR program, Perelman School of Medicine
Medical Director, Center for Cellular Immunotherapies, Perelman School of Medicine
CTSA Postdoctoral T32 Co-Program Director, Institute for Translational Medicine and Therapeutics
Department: Medicine
Contact information
Perelman Center for Advanced Medicine
3400 Civic Center Boulevard
Philadelphia, PA 19104
3400 Civic Center Boulevard
Philadelphia, PA 19104
Links
The Cell and Gene Therapy Toolkit for Junior Faculty
Penn Center for Myeloproliferative Neoplasms
The Cell and Gene Therapy Toolkit for Junior Faculty
Penn Center for Myeloproliferative Neoplasms
Education
A.B. (French/Comparative Area Studies)
Duke University, 1992.
(Premedical Studies)
Harvard University Extension School, 1994.
M.D. (Medicine)
Columbia College of Physicians and Surgeons, 1999.
M.S.T.R. (Translational Research)
University of Pennsylvania, 2009.
Permanent linkA.B. (French/Comparative Area Studies)
Duke University, 1992.
(Premedical Studies)
Harvard University Extension School, 1994.
M.D. (Medicine)
Columbia College of Physicians and Surgeons, 1999.
M.S.T.R. (Translational Research)
University of Pennsylvania, 2009.
Description of Research Expertise
Genetically modified T Cell TherapiesCAR T cells
Cellular therapy
Blood and Marrow Transplantation
Myeloproliferative Neoplasms
Umbilical Cord Blood Transplantation
Selected Publications
Nichols C, Frey N, Gill S, Hexner E, Hirsh RL, Hossain NM, Loren A, Martin ME, McCurdy SR, Munshi P, Perry L, Smith J, Litzky L, Madabhushi S, Baumrin E, Ahya VN, Porter DL.: Pulmonary Alveolar Proteinosis After Allogeneic Stem Cell Transplant in a Patient Undergoing Multiagent Chronic Graft-Versus-Host-Disease Treatment Including Axatilimab. Am J Hematol Oct 2026.Suzuki A, Zhao L, Thorsheim C, Weiderhold B, Yang C, Tutwiler V, Casu C, Myerson JW, Hexner EO, Mohandas N, Muzykantov VR, Litvinov RI, Nagaswami C, Risman RA, Ji P, Stalker TJ, Goldman AR, Tang HY, Speicher DW, Janmey PA, Rivella S, Tong W, Weisel JW, Svitkina TM, Abrams CS.: Aberrant erythrocyte rigidity in JAK2(V617F) myeloproliferative neoplasms underlies concurrent thrombosis and hemorrhage. Sci Transl Med 18: eadt0044, Oct 2026.
Gotlib, J., Reiter, A., Radia, D. H., Alvarez-Twose, I., Deininger, M. W., George, T. I., Panse, J. P., Mital, A., Pettit, K. M., Vannucchi, A. M., Platzbecker, U., Hermine, O., Elshoury, A., Livideanu, C., Mesa, R. A., Ustun, C., Triggiani, M., Dybedal, I., Jurcic, J. G., Zanotti, R., Oh, S. T., Yacoub, A., Hexner, E. O., Bose, P., Lee, S. G., Sperr, W. R., Griffiths, E. A., Butler, M., Lubke, J., Bidollari, I., Lin, H. M., Rylova, S. N., Dimitrijevic, S., Munoz-Gonzalez, J. I., DeAngelo, D. J.: Efficacy and safety of avapritinib in advanced systemic mastocytosis: 4-year follow-up of the PATHFINDER study. Blood Adv 10(10): 3676-3689, May 2026.
Barber-Rotenberg, J. S., Haas, A. R., Aggarwal, C., O'Hara, M., Hexner, E., Pequignot, E., Dowd, E., Ndeupen, S., Thai, E., Chen, F., Oner, B. S., Czuczman, C., Gonzalez, V. E., Fraietta, J. A., Hwang, W. T., Chew, A., Jadlowsky, J. K., Marshall, A., Shea, K. M., Jiang, Y., Cosey, A., Ferthio, R., Levine, B. L., Plesa, G., Siegel, D. L., Young, R. M., Sheppard, N. C., Albelda, S. M., June, C. H., Tanyi, J. L.: Phase 1 study of autologous T cells bearing fully human chimeric antigen receptors targeting mesothelin in mesothelin-expressing cancers. Mol Ther 34(5): 2653-2665, May 6 2026.
Xu, J., McCoy, M., Martinez, Z., Sussman, J. H., Gao, D., Vincent, T. L., Wang, H., Ma, C., Elghawy, O., Chen, G. M., Yang, A. G., Polonen, P., Natan, K., Shraim, R., Newman, H., Hofmann, T. J., Scoma, S., DiNofia, A. M., Hunger, S. P., Yang, J. J., Mullighan, C. G., Bernt, K. M., Hexner, E. O., Grupp, S. A., Watanabe, K., June, C. H., Tan, K., Teachey, D. T., Diorio, C.: CCR4 expression defines a targetable subset of T-cell acute lymphoblastic leukemia. Blood Adv 10(8): 2676-2686, Apr 28 2026.
Chen, G. M., Jain, A., Gering, D. T., Satulovsky, J., Datta, S., Lai, P., Karar, J., Gonzalez, V. E., Alexander, K., Chew, A., Jadlowsky, J. K., Ruella, M., Paruzzo, L., Amses, K. R., Rech, A. J., Stadtmauer, E. A., Frey, N. V., Hexner, E. O., Porter, D. L., Cohen, A. D., Gill, S. I., Garfall, A. L., Schuster, S. J., Mo, K. C., Liang, S. I., Spasic, M., Levine, B. L., Siegel, D. L., Ramirez-Fernandez, A., Cabanski, C. R., Yang, E., Mackall, C. L., Bushman, F. D., Good, Z., John Wherry, E., June, C. H., Fraietta, J. A.: Predictive biomarkers of response to chimeric antigen receptor (CAR) T-cell therapy for pan-haematologic cancer. Nat Biomed Eng 10(4): 803-814, Apr 2026.
Louloudis, I. E., Chen, Y. B., Spyrou, N., Alousi, A., Katsivelos, N., Ayuk, F., Weber, D., Hogan, W. J., Etra, A. M., Qayed, M., Aguayo-Hiraldo, P., Akahoshi, Y., Malki, M. M. A., Bolanos-Meade, J., Chanswangphuwana, C., Diniz, M., Eder, M., Hexner, E., Kitko, C. L., Kraus, S., Merli, P., Olson, T., MacMillan, M. L., Pidala, J., Reshef, R., Schechter, T., Wolfl, M., Baez, J., Eng, G., Gleich, S., Young, R., Nakamura, R., Ferrara, J. L. M., Levine, J. E.: Performance of Treatment Response Assessment at Day 7 by Baseline Acute Graft-versus-Host Disease Severity. Transplant Cell Ther 32(1): 63 e1-63 e11, Jan 2026.
Akahoshi Y, Katsivelos N, Louloudis IE, Weber D, Ayuk F, Hogan WJ, Chen YB, Etra AM, Aguayo-Hiraldo P, Chanswangphuwana C, Choe HK, Hexner EO, Kitko CL, Al Malki MM, Merli P, Olson TS, Qayed M, Vasova I, Wölfl M, Baez J, Eng G, Gleich S, Morales G, Spyrou N, Young R, Diniz M, Nakamura R, Levine JE, Ferrara JLM.: Systemic steroid treatment of grade I acute GVHD increases steroid-refractory GVHD and NRM. Blood Immunol Cell Ther 2026.
Gerds AT, Gotlib J, Abdelmessieh P, Ali H, Castells M, Chernak BJ, Espinoza-Gutarra MR, Fein Revell R, Green S, Gundabolu K, Hexner E, Jain T, Jamieson CH, Khan I, Kuykendall AT, Madanat YF, Masarova L, McMahon B, Mohan SR, Nadiminti KV, Oh S, Palmer J, Patel AB, Patel AA, Podoltsev N, Rein L, Salit R, Sehl M, Talpaz M, Wadleigh M, Wall SA, Bergman MA, Hochstetler C.: NCCN Guidelines® Insights: Myeloproliferative Neoplasms, Version 2.2026. J Natl Compr Canc Netw 2026.
Salit RB, Hexner EO, Gagelmann N, Kröger N, McLornan DP, Jain T, Gupta V, Hobbs GS, Tamari R, Robin M, Scott B, Saber W: Defining remission following hematopoietic cell transplant for myelofibrosis: an international expert panel consensus. Leukemia 39(12): 2862-2865, Dec 2025.